MENU
BCAX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Bicara Therapeutics (BCAX) Ownership - Who owns Bicara Therapeutics?
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
722.98M
P/E Ratio
N/A
Total Cash
520.76M
Projected Growth
N/A
Total Debt
445K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.55
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BCAX
Capitalization
723M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
521M
Total Cash/Share
9.55
Total Debt
445K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
510M
P/B Ratio
1.47
Cash Flow
N/A
Earnings
-1.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
36.01
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-81.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-11.35
Shares Held By Institutions
868M
Shares Outstanding - Current
54.5M
Total Liabilities
14.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-23.881
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information